The store will not work correctly when cookies are disabled.
2-Phenyl-4-[4-(3-pyrrolidin-1-yl-propoxy)-phenyl]-thiazole hydrochloride
ID: ALA1202682
PubChem CID: 14146327
Max Phase: Preclinical
Molecular Formula: C22H25ClN2OS
Molecular Weight: 364.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.c1ccc(-c2nc(-c3ccc(OCCCN4CCCC4)cc3)cs2)cc1
Standard InChI: InChI=1S/C22H24N2OS.ClH/c1-2-7-19(8-3-1)22-23-21(17-26-22)18-9-11-20(12-10-18)25-16-6-15-24-13-4-5-14-24;/h1-3,7-12,17H,4-6,13-16H2;1H
Standard InChI Key: KRNJLGZOPRWLMP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
10.0445 -2.2565 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7390 2.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2067 3.2905 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.9546 1.9903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9492 0.8772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4469 1.8311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4153 2.9701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8906 2.6991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.3937 1.2860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4213 0.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9460 0.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 -6.0109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3273 -7.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7945 -7.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5445 -6.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5408 -5.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.51 | Molecular Weight (Monoisotopic): 364.1609 | AlogP: 5.34 | #Rotatable Bonds: 7 |
Polar Surface Area: 25.36 | Molecular Species: BASE | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 9.37 | CX LogP: 5.02 | CX LogD: 3.06 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.53 | Np Likeness Score: -1.67 |
References
1. Sanfilippo PJ, Urbanski M, Press JB, Hajos ZG, Shriver DA, Scott CK.. (1988) Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity., 31 (9): [PMID:2842503] [10.1021/jm00117a018] |